Prostate cancer decisions — 2013

The Veteran's prostate disorder, including prostate cancer, is being remanded for further examination and opinion to determine if it is related to service exposure. The claim will be reviewed based on the new evidence.

The Veteran's prostate cancer was not shown to be related to service, including exposure to herbicides. The claim is denied.

The Veteran's appeal was dismissed as he withdrew his appeal for the rating reduction and the ratings assigned for residuals of prostate cancer.

The Board denied the appellant's claim to reopen a previously denied service connection for prostate cancer for accrued benefits purposes, finding that no new and material evidence had been received.

The Veteran's claims for service connection for bladder cancer with kidney blockage, prostate cancer (alleged Agent Orange exposure), and a compensable rating for gout were denied. The claim for prostate cancer was not reopened due to lack of new and material evidence.

The Veteran's prostate cancer is presumed to have resulted from his in-service herbicide exposure. The Veteran's appeal of service connection for hearing loss and tinnitus has been withdrawn.

The Veteran's claims for service connection were denied as there was no evidence of a direct relationship between his claimed conditions and his military service.

The Veteran's combination of service-connected migraine headaches, depressive disorder, PTSD associated with prostate cancer residuals, bilateral hearing loss, left foot injury, and impotence are found to be disabling enough to prevent him from securing or following substantial gainful employment.

The Veteran's claim for an increased rating for his service-connected prostate cancer is being remanded due to the need for a new VA examination and additional treatment records.

The Veteran's claim for a TDIU was granted effective May 6, 2009. The Board finds that the earlier effective date requested is not warranted.

The Veteran's appeal is being remanded for additional development, including obtaining private treatment records and scheduling a VA examination to assess the severity of his service-connected prostate cancer.

The Board has remanded the case to the RO for further consideration due to a failure to satisfy VA's duty to assist. The Veteran served in Thailand and claimed exposure to herbicides, but the records do not confirm this exposure. The case will be reconsidered based on the additional information obtained.

The Board denied service connection for the cause of the Veteran's death and denied service connection for prostate, throat, and pancreatic cancer for accrued benefit purposes only. The primary cause of death was metastatic pancreatic cancer, but the Veteran's prior history of prostate cancer contributed to significant debility.

The Board denied service connection for the claimed conditions as a result of herbicide exposure.

The Veteran's service-connected prostate cancer does not prevent him from securing and maintaining substantially gainful employment, as his disability is rated at 40 percent and he has completed four years of high school, two years of college, and additional training in photography, graphic arts, and electronic scanning. He last worked in August 2003.

The Board has remanded the case due to issues with communication and obtaining medical records. The appellant is seeking service connection for the cause of her husband's death, which may be related to his exposure to Agent Orange in service.

The Veteran's prostate cancer, status post radiation disability is currently rated at 30 percent disabling and the evidence does not support a higher rating.

The Veteran withdrew his appeals for the initial ratings of PTSD and depression, as well as prostate cancer prior to July 28, 2010.

The Board denied the appellant's claim of entitlement to service connection for the cause of the Veteran's death, finding that there is no evidence showing a direct relationship between his active service and his fatal prostate cancer.

The Veteran's claims for service connection for prostate cancer and erectile dysfunction have been reopened, and both conditions are now granted.,Prostatitis is also granted with a new rating.